Doc Hatton
@doc1982.bsky.social
Pharmacy professor with decades of experience.
#drugs #pharmaceuticals #medicine #pharmacy
#drugs #pharmaceuticals #medicine #pharmacy
FDA approves RAPIBLYK for treating supraventricular tachycardia
The generic name is landiolol. lan-DIE-oh-lol
www.accessdata.fda.gov/drugsatfda_d...
The generic name is landiolol. lan-DIE-oh-lol
www.accessdata.fda.gov/drugsatfda_d...
www.accessdata.fda.gov
December 6, 2024 at 7:38 PM
FDA approves RAPIBLYK for treating supraventricular tachycardia
The generic name is landiolol. lan-DIE-oh-lol
www.accessdata.fda.gov/drugsatfda_d...
The generic name is landiolol. lan-DIE-oh-lol
www.accessdata.fda.gov/drugsatfda_d...
FDA approves IOMERVU radiocontrast agent
The generic name is iomeprol. Eye-oh-MEH-prol
www.accessdata.fda.gov/drugsatfda_d...
The generic name is iomeprol. Eye-oh-MEH-prol
www.accessdata.fda.gov/drugsatfda_d...
www.accessdata.fda.gov
December 6, 2024 at 7:36 PM
FDA approves IOMERVU radiocontrast agent
The generic name is iomeprol. Eye-oh-MEH-prol
www.accessdata.fda.gov/drugsatfda_d...
The generic name is iomeprol. Eye-oh-MEH-prol
www.accessdata.fda.gov/drugsatfda_d...
FDA approves BIZENGRI for lung and pancreatic cancer
BIZENGRI® is a bispecific HER2- and HER3-directed antibody for treating cancer. The generic name is zenocutuzumab-zbco. Zen-oh-kue-TOOZ-you-mab--Zee-Bee-Cee-Oh
www.accessdata.fda.gov/drugsatfda_d...
BIZENGRI® is a bispecific HER2- and HER3-directed antibody for treating cancer. The generic name is zenocutuzumab-zbco. Zen-oh-kue-TOOZ-you-mab--Zee-Bee-Cee-Oh
www.accessdata.fda.gov/drugsatfda_d...
www.accessdata.fda.gov
December 6, 2024 at 7:34 PM
FDA approves BIZENGRI for lung and pancreatic cancer
BIZENGRI® is a bispecific HER2- and HER3-directed antibody for treating cancer. The generic name is zenocutuzumab-zbco. Zen-oh-kue-TOOZ-you-mab--Zee-Bee-Cee-Oh
www.accessdata.fda.gov/drugsatfda_d...
BIZENGRI® is a bispecific HER2- and HER3-directed antibody for treating cancer. The generic name is zenocutuzumab-zbco. Zen-oh-kue-TOOZ-you-mab--Zee-Bee-Cee-Oh
www.accessdata.fda.gov/drugsatfda_d...
Attruby (acoramidis) approved for cardiomyopathy
#FDA approved Attruby (acoramidis) to treat adults with cardiomyopathy associated with transthyretin-mediated amyloidosis. My best generic pronunciation guess is Ah-koe-AM-id-is. I will post pronunciations for new drugs.
www.fda.gov/drugs/news-e...
#FDA approved Attruby (acoramidis) to treat adults with cardiomyopathy associated with transthyretin-mediated amyloidosis. My best generic pronunciation guess is Ah-koe-AM-id-is. I will post pronunciations for new drugs.
www.fda.gov/drugs/news-e...
FDA approves drug for heart disorder caused by transthyretin-mediated
The U.S. Food and Drug Administration has approved Attruby (acoramidis) to treat adults with cardiomyopathy (disorder that affects heart muscle) of wild-type or variant (hereditary) transthyretin-medi...
www.fda.gov
November 25, 2024 at 9:01 PM
Attruby (acoramidis) approved for cardiomyopathy
#FDA approved Attruby (acoramidis) to treat adults with cardiomyopathy associated with transthyretin-mediated amyloidosis. My best generic pronunciation guess is Ah-koe-AM-id-is. I will post pronunciations for new drugs.
www.fda.gov/drugs/news-e...
#FDA approved Attruby (acoramidis) to treat adults with cardiomyopathy associated with transthyretin-mediated amyloidosis. My best generic pronunciation guess is Ah-koe-AM-id-is. I will post pronunciations for new drugs.
www.fda.gov/drugs/news-e...
End Drug Shortages Act
This Senate bill would amend the Food, Drug, and Cosmetic Act to improve drug shortages. It would improve shortage communication among stakeholders, monitor demand surges, require the FDA to consider shortage reports, and more.
www.kaine.senate.gov/imo/media/do...
This Senate bill would amend the Food, Drug, and Cosmetic Act to improve drug shortages. It would improve shortage communication among stakeholders, monitor demand surges, require the FDA to consider shortage reports, and more.
www.kaine.senate.gov/imo/media/do...
www.kaine.senate.gov
November 22, 2024 at 8:15 PM
End Drug Shortages Act
This Senate bill would amend the Food, Drug, and Cosmetic Act to improve drug shortages. It would improve shortage communication among stakeholders, monitor demand surges, require the FDA to consider shortage reports, and more.
www.kaine.senate.gov/imo/media/do...
This Senate bill would amend the Food, Drug, and Cosmetic Act to improve drug shortages. It would improve shortage communication among stakeholders, monitor demand surges, require the FDA to consider shortage reports, and more.
www.kaine.senate.gov/imo/media/do...
Florida's Plan to Import Drugs from Canada Goes Nowhere
No surprise here. Canada wants states in the US to refrain from importing drugs. That might lead to shortages in Canada or, worse yet, drug companies raising prices in Canada.
kffhealthnews.org/news/article...
No surprise here. Canada wants states in the US to refrain from importing drugs. That might lead to shortages in Canada or, worse yet, drug companies raising prices in Canada.
kffhealthnews.org/news/article...
Florida Gov. DeSantis’ Canadian Drug Import Plan Goes Nowhere After FDA Approval - KFF Health News
Florida sued the FDA over what it said was a “reckless delay” in approving its drug importation plan. Now, nearly a year after the FDA gave the state the green light, the program has yet to begin.
kffhealthnews.org
November 21, 2024 at 8:57 PM
Florida's Plan to Import Drugs from Canada Goes Nowhere
No surprise here. Canada wants states in the US to refrain from importing drugs. That might lead to shortages in Canada or, worse yet, drug companies raising prices in Canada.
kffhealthnews.org/news/article...
No surprise here. Canada wants states in the US to refrain from importing drugs. That might lead to shortages in Canada or, worse yet, drug companies raising prices in Canada.
kffhealthnews.org/news/article...
Oral Phenylephrine (eg, Sudafed PE) is ineffective.
I have worked for 20 years to get this ineffective OTC oral, nasal decongestant off the market. Recently FDA proposed to remove it from the market.
www.fda.gov/news-events/...
www.nytimes.com/2023/09/29/o...
I have worked for 20 years to get this ineffective OTC oral, nasal decongestant off the market. Recently FDA proposed to remove it from the market.
www.fda.gov/news-events/...
www.nytimes.com/2023/09/29/o...
Opinion | We’ve Known for 20 Years This Cold Medicine Doesn’t Work (Published 2023)
And that is just the tip of the iceberg.
www.nytimes.com
November 21, 2024 at 8:53 PM
Oral Phenylephrine (eg, Sudafed PE) is ineffective.
I have worked for 20 years to get this ineffective OTC oral, nasal decongestant off the market. Recently FDA proposed to remove it from the market.
www.fda.gov/news-events/...
www.nytimes.com/2023/09/29/o...
I have worked for 20 years to get this ineffective OTC oral, nasal decongestant off the market. Recently FDA proposed to remove it from the market.
www.fda.gov/news-events/...
www.nytimes.com/2023/09/29/o...
The REMS for Mifepristone should be removed
Check out our recent publication in the Journal of the American College of Clinical Pharmacy.
accpjournals.onlinelibrary.wiley.com/doi/abs/10.1...
Check out our recent publication in the Journal of the American College of Clinical Pharmacy.
accpjournals.onlinelibrary.wiley.com/doi/abs/10.1...
Restrictions on pharmacist dispensing of mifepristone remain a hard pill to swallow
This analysis explores the basis for the US Food and Drug Administration (FDA) requiring a Risk Evaluation and Mitigation Strategy (REMS) for mifepristone for the termination of intrauterine pregnanc...
accpjournals.onlinelibrary.wiley.com
November 21, 2024 at 8:46 PM
The REMS for Mifepristone should be removed
Check out our recent publication in the Journal of the American College of Clinical Pharmacy.
accpjournals.onlinelibrary.wiley.com/doi/abs/10.1...
Check out our recent publication in the Journal of the American College of Clinical Pharmacy.
accpjournals.onlinelibrary.wiley.com/doi/abs/10.1...